Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
7.18
+0.05 (0.70%)
Oct 9, 2026, 10:14 AM EDT - Market open
Phathom Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $26 | Buy | Maintains | $26 | +262.12% | Sep 21, 2026 |
| Leerink Partners | Leerink Partners | Hold Initiates $10 | Hold | Initiates | $10 | +39.28% | Sep 9, 2026 |
| Barclays | Barclays | Buy Maintains $14 | Buy | Maintains | $14 | +94.99% | Aug 17, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $22 → $20 | Buy | Reiterates | $22 → $20 | +178.55% | Jul 31, 2026 |
| Raymond James | Raymond James | Buy Maintains $21 | Buy | Maintains | $21 | +192.48% | Jul 31, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $25 → $22 | Buy | Maintains | $25 → $22 | +206.41% | Jul 31, 2026 |
| Needham | Needham | Buy Maintains $28 → $22 | Buy | Maintains | $28 → $22 | +206.41% | Jul 30, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Apr 30, 2026 |